新闻中心

NEWS CENTER

Sungene biotech gives rewards to two Nankai university students



Recently, research team of Dr. Wen Ti and Lin Yuquan in Life Science of Nankai University who used our antibody reagents, successfully published two important scholarly articles titled "Therapeutic effects of a novel Tylophorine analog NK-007 on collagen-induced arthritis through suppressing TNF-α production and Th17 differentiationt, "and" the mouse Mageb18 gene encodes a ubiquitously expressed type I MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cells " in important international academic journal arthritis & Rheumatism (ranked first in arthritis research area, impact factor 8.435), the results showed new small molecule compound for treatment of rheumatoid arthritis in mice, it contributed a lot to the development of novel biological agents for treatment of human rheumatoid arthritis. According to company's commitment: someone who used our biological antibody reagents for academic research and published papers high level of SCI, will gain award from Sungene, Sungene awarded the first author Wen Ti and Lin Yuquan separately two thousand RMB for each paper.


Go back to previous page

Previous chapter:  Sungene biotech succ...

Next chapter:  Sungene biotech gain...Publication date: 2015-12-18